Atossa Genetics (ATOS)
(Delayed Data from NSDQ)
$1.42 USD
+0.04 (2.90%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $1.41 -0.01 (-0.70%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.42 USD
+0.04 (2.90%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $1.41 -0.01 (-0.70%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth D Momentum C VGM
Zacks News
Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?
by Zacks Equity Research
Here is how Atossa Genetics Inc. (ATOS) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Atossa Genetics Inc. (ATOS) and CorMedix (CRMD) have performed compared to their sector so far this year.
Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Atossa Genetics Inc. (ATOS) and DiaMedica Therapeutics, Inc. (DMAC) have performed compared to their sector so far this year.
Are You Looking for a Top Momentum Pick? Why Atossa Genetics Inc. (ATOS) is a Great Choice
by Zacks Equity Research
Does Atossa Genetics Inc. (ATOS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?
by Zacks Equity Research
Here is how Atossa Genetics Inc. (ATOS) and Hologic (HOLX) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Alvotech (ALVO) This Year?
by Zacks Equity Research
Here is how Alvotech (ALVO) and Atossa Genetics Inc. (ATOS) have performed compared to their sector so far this year.
Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Atossa Genetics Inc. (ATOS) and Ocugen (OCGN) have performed compared to their sector so far this year.
Atossa Genetics Inc. (ATOS) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Atossa Genetics Inc. (ATOS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Atossa (ATOS) Reports Positive Results From EVANGELINE Study
by Zacks Equity Research
Atossa (ATOS) unveils positive results from its phase 2 EVANGELINE clinical study, which shows that (Z)-endoxifen can reduce the growth of ER+ breast cancer.
Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Atossa Genetics Inc. (ATOS) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.